Page last updated: 2024-11-06

salazodin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

salazodin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65707
CHEMBL ID2105427
CHEMBL ID4303413
SCHEMBL ID1224095
MeSH IDM0055065

Synonyms (40)

Synonym
salazodine
salazopyridazin
salazodine [inn]
salazodino [inn-spanish]
2-hydroxy-5-((4-(((6-methoxy-3-pyridazinyl)amino)sulfonyl)phenyl)azo)benzoic acid
brn 0866238
salazopyridazine
benzoic acid, 2-hydroxy-5-((4-(((6-methoxy-3-pyridazinyl)amino)sulfonyl)phenyl)azo)-
salazodin
5-((p-((6-methoxy-3-pyridazinyl)sulfamoyl)phenyl)azo)salicylic acid
salicylic acid, 5-((p-((6-methoxy-3-pyridazinyl)sulfamoyl)phenyl)azo)-
salazodinum [inn-latin]
5-(4-((6-methoxy-3-pyridazinyl)sulfamoyl)phenylazo)salicylsaeure
AKOS005267173
22933-72-8
salazodinum
4l219q1d16 ,
unii-4l219q1d16
salazodino
CHEMBL2105427
2-hydroxy-5-[(4-{[(6-methoxy-3-pyridazinyl)amino]-sulfonyl}phenyl)diazenyl]benzoic acid
AKOS022193762
MLS006010939
smr004703039
SCHEMBL1224095
mfcd00864769
2-hydroxy-5-[(4-{[(6-methoxypyridazin-3-yl)amino]sulfonyl}phenyl)diazenyl]benzoic acid
2-hydroxy-5-[(e)-(4-{[(6-methoxypyridazin-3-yl)amino]sulfonyl}phenyl)diazenyl]benzoic acid
2-hydroxy-5-[[4-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl]diazenyl]benzoic acid
2-hydroxy-5-[(4-([(6-methoxypyridazin-3-yl)amino]sulfonyl)phenyl)diazenyl]benzoic acid
CHEMBL4303413
Q27259921
F83870
2-hydroxy-5-[(1e)-2-{4-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl}diazen-1-yl]benzoic acid
LS-09579
3-(2-{4-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid
DTXSID40865074
HY-145455
CS-0374748
DTXSID001043229

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"If SASP is initiated at a low dosage (≤ 500 mg) and increased up to 1000 mg under careful monitoring, it is safe for HD patients."( Retrospective study of salazosulfapyridine in eight patients with rheumatoid arthritis on hemodialysis.
Akiyama, Y; Furuta, E; Kato, Y; Mimura, T; Sakurai, Y, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (54.55)18.7374
1990's4 (36.36)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.15 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (13.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.67%)4.05%
Observational0 (0.00%)0.25%
Other12 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]